| (210) | Number of the EPO application | 17761907 |
| (220) | Filing date of the EPO application | 2017.09.11 |
| (80) | EPO patent specification publication (B) | EPB nr. 47/2021, 2021.11.24 |
| (110) | EPO patent number | 3510044 |
| (21) | Number of the application | e 2019 0768 |
| (71) | Name(s) of applicant(s), code of the country | Zealand Pharma A/S, DK; |
| (72) | Name(s) of inventor(s), code of the country | MATHIESEN Jesper Mosolff, DK;
GIEHM Lise, DK;
MUNCH Henrik Kofoed, DK;
VILLADSEN Jesper Skodborg, DK;
HAMPRECHT Dieter Wolfgang, DE;
HEIM-RIETHER Alexander, DE;
FOSSATI Giacomo, DE; |
| (73) | Name(s) of owner(s), code of the country | Zealand Pharma A/S, DK; |
| (54) | Title of the invention | AMYLIN ANALOGUES |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C07K 14/575 (2006.01.01); A61K 38/22 (2006.01.01); A61P 5/48 (2006.01.01) |
| (19) | Country | DK |
| (41) | Date of publication of the application | 2019.08.31 |
| (30) | Priority | 16188024, 2016.09.09, EP |
| (86) | International application | PCT/EP2017/072718, 2017.09.11 |
| (87) | International publication | WO 2018/046719, 2018.03.15 |